His primary areas of study are Internal medicine, Gastroenterology, Immunology, Surgery and Odds ratio. The study of Internal medicine is intertwined with the study of Pathology in a number of ways. His study in Gastroenterology is interdisciplinary in nature, drawing from both Viral hepatitis, Hepatitis B and Hepatitis.
His Immunology research is multidisciplinary, incorporating perspectives in Crohn's disease and Genotype. He combines subjects such as Retinopathy and Gallbladder Emptying with his study of Surgery. His Odds ratio research also works with subjects such as
Internal medicine, Gastroenterology, Immunology, Surgery and Inflammatory bowel disease are his primary areas of study. As a member of one scientific family, he mostly works in the field of Internal medicine, focusing on Oncology and, on occasion, Pancreatic cancer. His work on Helicobacter pylori as part of general Gastroenterology study is frequently linked to In patient, therefore connecting diverse disciplines of science.
Angelo Andriulli has included themes like Single-nucleotide polymorphism, Genotype, Disease and Allele in his Immunology study. His Inflammatory bowel disease study combines topics from a wide range of disciplines, such as Crohn's disease and Ulcerative colitis. His Cirrhosis study frequently draws connections between related disciplines such as Hepatocellular carcinoma.
Angelo Andriulli mostly deals with Internal medicine, Gastroenterology, Oncology, Inflammatory bowel disease and Cirrhosis. Angelo Andriulli performs integrative Internal medicine and In patient research in his work. His Gastroenterology research includes themes of Urine and Confidence interval.
The concepts of his Oncology study are interwoven with issues in Disease, Genetic predisposition, microRNA, Colorectal cancer and Adenocarcinoma. His research in Inflammatory bowel disease intersects with topics in Crohn's disease, Ustekinumab, Adverse effect and Ulcerative colitis. His Cirrhosis research is multidisciplinary, relying on both Ribavirin, Hepatitis C virus, Surgery and Hepatitis C.
Angelo Andriulli spends much of his time researching Internal medicine, Pancreatic cancer, Gastroenterology, Inflammatory bowel disease and Bioinformatics. His Internal medicine research integrates issues from Surgery and Oncology. His research investigates the connection between Pancreatic cancer and topics such as Case-control study that intersect with issues in Confidence interval, Metabolomics, Pancreatitis, chronic, Risk factor and High dimensionality.
Angelo Andriulli incorporates Gastroenterology and Alcohol abuse in his studies. Angelo Andriulli combines subjects such as Ulcerative colitis, Messenger RNA, Crohn's disease, Gene silencing and Computational biology with his study of Inflammatory bowel disease. His work in Genotype addresses issues such as Genetic variation, which are connected to fields such as Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways
Heather J. Cordell;Younghun Han;George F. Mells;Yafang Li.
Nature Communications (2015)
Aberrant DNA methylation in non-neoplastic gastric mucosa of H. pylori infected patients and effect of eradication
Francesco Perri;Rosa Cotugno;Ada Piepoli;Antonio Merla.
The American Journal of Gastroenterology (2007)
Patterns of symptoms in functional dyspepsia: role of Helicobacter pylori infection and delayed gastric emptying.
Francesco Perri;Rocco Clemente;Virginia Festa;Vito Annese.
The American Journal of Gastroenterology (1998)
Meta-analysis of somatostatin, octreotide and gabexate mesilate in the therapy of acute pancreatitis
A Andriulli;G Leandro;R Clemente;V Festa.
Alimentary Pharmacology & Therapeutics (1998)
Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms.
Alberto Pilotto;Davide Seripa;Marilisa Franceschi;Marilisa Franceschi;Carlo Scarcelli.
Characteristics of hepatocellular carcinoma in Italy
Tommaso Stroffolini;Pietro Andreone;Angelo Andriulli;Antonio Ascione.
Journal of Hepatology (1998)
Neoadjuvant/Preoperative Gemcitabine for Patients with Localized Pancreatic Cancer: A Meta-analysis of Prospective Studies
Angelo Andriulli;Virginia Festa;Edoardo Botteri;Edoardo Botteri;Maria R. Valvano.
Annals of Surgical Oncology (2012)
HCV and diabetes mellitus: evidence for a negative association.
Alessandra Mangia;Giuseppe Schiavone;Giovanni Lezzi;Riccardo Marmo.
The American Journal of Gastroenterology (1998)
Rifabutin-based 'rescue therapy' for Helicobacter pylori infected patients after failure of standard regimens.
F Perri;V Festa;R Clemente;M Quitadamo.
Alimentary Pharmacology & Therapeutics (2000)
Mirna expression profiles identify drivers in colorectal and pancreatic cancers.
Ada Piepoli;Francesca Tavano;Massimiliano Copetti;Tommaso Mazza.
PLOS ONE (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: